Process Development Engineer I, Cell Culture
Regeneron Pharmaceuticals
Summary
At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Process Development Engineer to join our Cell Culture Development Group within Preclinical Manufacturing and Process Development (PMPD), supporting early-stage development in a non-GMP process development laboratory. In this role, you will develop production processes for monoclonal antibodies by screening top candidates, selecting cell lines, and developing media and feeds while collaborating with cell line development, purification, analytics, and manufacturing teams.
Job description
Discover Your Role
- Design and develop cell culture studies from shaker flasks to single-use and glass bench-scale bioreactors (2L to 15L)
- Screen top-tier antibody candidates, select cell lines, and develop media and feed formulations
- Prepare media, feeds, buffers, and reagents, and operate and maintain bioreactor and analytical equipment
- Analyze data statistically and manage critical data in a highly organized manner
- Partner with colleagues in cell line development, scale-up, purification, analytics, and manufacturing
- Author development reports, document your work, and review manufacturing records
- Support technology transfer through written process transmittals, troubleshooting, and on-site support for manufacturing campaigns in Albany, NY
Please note: this role requires weekend work and occasional travel to upstate NY
This Role Requires
- BS or MS in Chemical Engineering or Bio-related Engineering with 0-2 years of experience in a laboratory setting
- Excellent verbal and written communication skills, and record-keeping abilities to accurately record, analyze, and document development data
- Strong initiative and drive to complete ambitious tasks and learn new technologies
- You work well both independently and in a team, balancing multiple projects at once
- Contribute to lab equipment maintenance and safety to keep a safe, effective, and efficient working environment
- Preferred: Experience with mammalian cell culture
- Preferred: Experience developing fed-batch bioreactor processes, including optimizing feeding strategies and evaluating cell culture media and feed formulations
- Preferred: Experience with ambr250 and with statistical design and analysis software (e.g., JMP)
Requirements
- BS or MS in Chemical Engineering or Bio-related Engineering
- 0-2 years of experience in a laboratory setting
- Excellent verbal and written communication skills
- Record-keeping abilities to accurately record, analyze, and document development data
- Strong initiative and drive to complete ambitious tasks and learn new technologies
- Ability to work well both independently and in a team
- Ability to balance multiple projects at once
- Contribute to lab equipment maintenance and safety
- Preferred: Experience with mammalian cell culture
- Preferred: Experience developing fed-batch bioreactor processes
- Preferred: Experience optimizing feeding strategies and evaluating cell culture media and feed formulations
- Preferred: Experience with ambr250
- Preferred: Experience with statistical design and analysis software (e.g., JMP)
Benefits
- Annual Bonuses
- Incentive Plans
- Equity Awards
- Pension Or Retirement Benefits
- 401(k) Company Match
- Health And Wellness Programs
- Fitness Centers
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Paid Time Off
- Family Support Benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.